Abbott Laboratories stock consolidates near $105.70 with technical signals mixed

Traders Union
All News
Business & Wealth
Companies
Abbott Laboratories rises 0.09% today

Highlights

Abbott Laboratories shows strong short- and medium-term bullish momentum but faces significant long-term resistance near $108.50.
The stock is consolidating between $103 and $110, with recent gains muted by an overbought technical profile.
Downside risk dominates the weekly trend, suggesting further declines could test support near $98.57 if $103 is breached.

Abbott Laboratories states that families and healthcare professionals turn to Pedialyte when hydration matters most. Details are being clarified.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish positioning curtailed by long-term resistance and support boundaries

Abbott Laboratories ($105.70) is above its SMA-20 ($98.57) and SMA-50 ($92.96), indicating continued short- and medium-term bullish momentum, but remains below its SMA-200 ($108.48), suggesting lingering long-term resistance. The Ichimoku Kijun on D1 is at $98.84, which is immediate support, while the closest near-term resistance is the SMA-200 at $108.48 and key resistance comes in at the Ichimoku Kijun and SMA-100 levels; near-term support lies at SMA-20 ($98.57), with key support at SMA-50 ($92.96).

Upward momentum persisting as overbought conditions and volatility increase

Momentum on D1 remains bullish, with MACD and ADX both giving buy signals, though Stoch RSI is at strongly overbought levels (77.22) and the BBP indicator confirms overbought conditions with positive buyer dominance. RSI and CCI also signal a buy, underscoring continued upward momentum. Abbott Laboratories has risen $2.60 (2.52%) over the past week, trading at $105.70, up from last week's close at $103.10. The price is in the lower part of this week's range, with weekly volatility standing at 6.44%. The tone this week shows recovery off the earlier lows but remains well below the weekly high, indicating ongoing consolidation after a midweek retreat.

Downside risk favored as consolidation persists near yearly lows

For the coming week, the expected trading range is between $103.00 and $110.00, reflecting typical volatility and recent price behavior. The probability of a further price increase is very low (less than 20%), given that only RSI on W1 provides a buy signal, while ADX, MACD, and MA-50 on W1 all signal weakness. Downward movement appears much more likely as sellers have the edge on the weekly trend. The baseline scenario is sideways action between $103 and $110 as the price consolidates near the lower band of the recent range. The bullish scenario would require a breakout above $108.50 to challenge resistance near $110, while a bearish scenario could see the price breaking below $103, exposing support near $98.57. With the current price well above the 52-week low ($81.97) but still far from the 52-week high ($137.49), Abbott Laboratories remains firmly in the lower half of its annual range.

Earlier, analysts noted that Abbott Laboratories was exhibiting strong bullish momentum in the short term, supported by solid earnings and improved guidance, despite lingering long-term challenges. As the current environment unfolds, investors should monitor for shifts in momentum or emerging catalysts that could redefine the prevailing scenario.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.